Mitochondrial Dysfunction Contributes to Impaired Cytokine Production of CD56bright Natural Killer Cells From Human Immunodeficiency Virus-Infected Individuals Under Effective Antiretroviral Therapy.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
13 09 2022
Historique:
received: 16 12 2021
accepted: 18 03 2022
pubmed: 22 3 2022
medline: 16 9 2022
entrez: 21 3 2022
Statut: ppublish

Résumé

Human immunodeficiency virus (HIV) infection is associated with impaired natural killer (NK) cell activity, which is only incompletely restored under antiretroviral therapy. Analyzing the bioenergetics profiles of oxygen consumption, we observed that several parameters were significantly reduced in HIV+ NK cells, indicating a mitochondrial defect. Accordingly, we found HIV+ CD56bright NK cells to display a decreased mitochondrial membrane potential and mitochondrial mass. Both parameters were positively correlated with interferon gamma (IFN-γ) production of NK cells. Finally, we demonstrated that stimulation of HIV+ NK cells with MitoTEMPO, a mitochondria-targeting antioxidant, significantly improved IFN-γ production. We identified mitochondrial dysfunction as a mechanism that contributes to impaired NK cell function.

Identifiants

pubmed: 35313340
pii: 6551690
doi: 10.1093/infdis/jiac103
doi:

Substances chimiques

CD56 Antigen 0
Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

901-906

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Déclaration de conflit d'intérêts

Potential conflicts of interest. G. J. R. has received travel expenses and honoraria from Gilead. C. B. has received honoraria for consulting or speaking at educational events from AbbVie, Gilead, Janssen, MSD, and ViiV. J. K. R. has received honoraria for consulting or speaking at educational events from Abivax, Gilead, Janssen, Merck, Theratechnologies, and ViiV. All other authors report no potential conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Auteurs

Michael ToVinh (M)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Gregor Hörr (G)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Kristiyana Dobrikova (K)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Christina Gotter (C)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Clemens Rommel (C)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Christoph Hoffmeister (C)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Jan Raabe (J)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Kim M Kaiser (KM)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Claudia Finnemann (C)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Jenny Bischoff (J)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Gereon J Rieke (GJ)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Christoph Wilhelm (C)

Immunopathology Unit, Institute of Clinical Chemistry and Clinical Pharmacology, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Vanessa Schmitt (V)

Immunopathology Unit, Institute of Clinical Chemistry and Clinical Pharmacology, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Christoph Möhl (C)

German Center for Neurodegenerative Diseases, Image and Data Analysis Facility, Bonn, Germany.

Mansoureh Aghabeig (M)

German Center for Neurodegenerative Diseases, Image and Data Analysis Facility, Bonn, Germany.

Carolynne Schwarze-Zander (C)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Christoph Boesecke (C)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Kathrin van Bremen (K)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Jan Christian Wasmuth (JC)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Christian P Strassburg (CP)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Jürgen K Rockstroh (JK)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Ulrich Spengler (U)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Benjamin Krämer (B)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.

Jacob Nattermann (J)

Department of Internal Medicine I, Medical Faculty, University Hospital Bonn, University of Bonn, Bonn, Germany.
German Center for Infection Research, Thematical Translational Units HIV, Cologne/Bonn, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH